MUSCLE REGENERATION: THE NEXT HORIZON! Trademark

Trademark Overview


On Tuesday, April 16, 2024, a trademark application was filed for MUSCLE REGENERATION: THE NEXT HORIZON! with the United States Patent and Trademark Office. The USPTO has given the MUSCLE REGENERATION: THE NEXT HORIZON! trademark a serial number of 98502898. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Wednesday, November 6, 2024. This trademark is owned by Satellos Bioscience Inc.. The MUSCLE REGENERATION: THE NEXT HORIZON! trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Providing medical scientific research information in the fields of medical sciences, biochemistry and biotechnology, pharmacology, pharmaceuticals, biologics, vaccines, muscle stem cells, muscle repair and regeneration, and musculoskeletal diseases, disorders, and conditions; Research and development in the fields of medical sciences, biochemistry and biotechnology, pharmacology, pharmaceuticals, biologics, vaccines, muscle stem cells, muscle repair and regeneration, and musculoskeletal diseases, disorders, and conditions; Consulting services in the fields of medical sciences, biochemistry and biotechnology, pharmacology, pharmaceuticals, biologics, vaccines, muscle stem cells, muscle repair and regeneration, and musculoskeletal diseases, disorders, and conditions; Development of computer software platforms in the fields of medical sciences, biochemistry and biotechnology, and pharmacology; Platform as a service (PAAS) featuring computer software platforms for use in cell imaging, cell...
muscle regeneration: the next horizon!

General Information


Serial Number98502898
Word MarkMUSCLE REGENERATION: THE NEXT HORIZON!
Filing DateTuesday, April 16, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateWednesday, November 6, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesProviding medical scientific research information in the fields of medical sciences, biochemistry and biotechnology, pharmacology, pharmaceuticals, biologics, vaccines, muscle stem cells, muscle repair and regeneration, and musculoskeletal diseases, disorders, and conditions; Research and development in the fields of medical sciences, biochemistry and biotechnology, pharmacology, pharmaceuticals, biologics, vaccines, muscle stem cells, muscle repair and regeneration, and musculoskeletal diseases, disorders, and conditions; Consulting services in the fields of medical sciences, biochemistry and biotechnology, pharmacology, pharmaceuticals, biologics, vaccines, muscle stem cells, muscle repair and regeneration, and musculoskeletal diseases, disorders, and conditions; Development of computer software platforms in the fields of medical sciences, biochemistry and biotechnology, and pharmacology; Platform as a service (PAAS) featuring computer software platforms for use in cell imaging, cell analysis, drug discovery, and drug target discovery in the fields of medical sciences, biochemistry and biotechnology, pharmacology, pharmaceuticals, biologics, vaccines, muscle stem cells, muscle repair and regeneration, and musculoskeletal diseases, disorders, and conditions.

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, April 16, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSatellos Bioscience Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressToronto M5J2J3
CA

Trademark Events


Event DateEvent Description
Tuesday, April 16, 2024NEW APPLICATION ENTERED
Sunday, September 29, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, October 29, 2024ASSIGNED TO EXAMINER
Wednesday, November 6, 2024NON-FINAL ACTION WRITTEN
Wednesday, November 6, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, November 6, 2024NON-FINAL ACTION E-MAILED